STAT+: Pharmalittle: Were reading about Trump&#821...

What’s Happening

Breaking it down: The Trump administration just dropped 100% tariffs on imported brand-name drugs, but with significant caveats Pharmalot Pharmalot STAT Plus: Up and down the ladder: The latest comings and goings By Ed Silverman Pharmalot Pharmalot STAT Plus: Pharmalittle: Were reading about Trump tariff plans, FDAs OK for a Lilly obesity pill, and more By Ed Silverman Pharmalot Pharmalot STAT Plus: Government watchdog urges FDA to finalize guidance for advisory committee conflicts of interest By Ed Silverman Pharmalot Pharmalot STAT Plus: Pharmalittle: Were reading about FDA view on peptide compounding, Iran war hurting trial recruitment, and more By Ed Silverman Pharmalot Pharmalot STAT Plus: Pharmalittle: Were reading about pharma delaying launches in Europe, Lilly and Biogen deals, and more By Ed Silverman STAT Plus: How a Texas couple is getting rich off out-of-network medical bills By Tara Bannow STAT Plus: Ba hit speed bump in quest to grow custom gene editor By Jason Mast STAT Plus: In private meetings, White House works to win pharma companies support for drug pricing bill By Daniel Payne STAT Plus: HSA companies struck it big in Trump’s tax bill.

More details are expected to emerge soon.

Why This Matters

Health experts are weighing in on what this means for people.

This is the kind of health news that affects everyday decisions.

The Bottom Line

This story is still developing, and we’ll keep you updated as more info drops.

We want to hear your thoughts on this.